These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37768184)

  • 1. Impact of Human Immunodeficiency Virus and Peripartum Period on Mycobacterium tuberculosis Infection Detection.
    Escudero JN; Mecha J; Richardson BA; Maleche-Obimbo E; Matemo D; Kinuthia J; John-Stewart G; LaCourse SM
    J Infect Dis; 2023 Dec; 228(12):1709-1719. PubMed ID: 37768184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting.
    LaCourse SM; Cranmer LM; Matemo D; Kinuthia J; Richardson BA; Horne DJ; John-Stewart G
    J Acquir Immune Defic Syndr; 2017 May; 75(1):128-136. PubMed ID: 28141782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal HIV Status and Risk of Infant Mycobacterium tuberculosis Infection as Measured by Tuberculin Skin Test.
    Mecha J; Escudero JN; Richardson BA; Maleche-Obimbo E; Matemo D; Kinuthia J; John-Stewart G; LaCourse SM
    Pediatr Infect Dis J; 2024 Mar; 43(3):250-256. PubMed ID: 37991383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon Gamma Release Assay and Tuberculin Skin Test Performance in Pregnant Women Living With and Without HIV.
    Kaplan SR; Escudero JN; Mecha J; Richardson BA; Maleche-Obimbo E; Matemo D; Kinuthia J; John-Stewart GC; LaCourse SM
    J Acquir Immune Defic Syndr; 2022 Jan; 89(1):98-107. PubMed ID: 34629414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.
    Mathad JS; Bhosale R; Balasubramanian U; Kanade S; Mave V; Suryavanshi N; Gupte N; Joshi S; Chandanwale A; Dupnik KM; Kulkarni V; Deshpande P; Fitzgerald DW; Gupta A
    Am J Respir Crit Care Med; 2016 Jun; 193(12):1421-8. PubMed ID: 26765255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stages of pregnancy and HIV affect diagnosis of tuberculosis infection and Mycobacterium tuberculosis (MTB)-induced immune response: Findings from PRACHITi, a cohort study in Pune, India.
    Bhosale R; Alexander M; Deshpande P; Kulkarni V; Gupte N; Gupta A; Mathad J
    Int J Infect Dis; 2021 Nov; 112():205-211. PubMed ID: 34517050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting.
    König Walles J; Tesfaye F; Jansson M; Tolera Balcha T; Winqvist N; Kefeni M; Garoma Abeya S; Belachew F; Sturegård E; Björkman P
    PLoS One; 2018; 13(4):e0193589. PubMed ID: 29617458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-IFNγ Whole Blood Cytokine Responses to Mycobacterium tuberculosis Antigens in HIV-exposed Infants.
    Anterasian C; Warr AJ; Lacourse SM; Kinuthia J; Richardson BA; Nguyen FK; Matemo D; Maleche-Obimbo E; John Stewart GC; Hawn TR
    Pediatr Infect Dis J; 2021 Oct; 40(10):922-929. PubMed ID: 34525006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV).
    Pettit AC; Stout JE; Belknap R; Benson CA; Séraphin MN; Lauzardo M; Horne DJ; Garfein RS; Maruri F; Ho CS;
    Clin Infect Dis; 2021 Oct; 73(7):e2278-e2284. PubMed ID: 32761083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculin skin test and QuantiFERON-TB Gold In-tube Test for latent tuberculosis in Thai HIV-infected adults.
    Khawcharoenporn T; Apisarnthanarak A; Phetsuksiri B; Rudeeaneksin J; Srisungngam S; Mundy LM
    Respirology; 2015 Feb; 20(2):340-7. PubMed ID: 25428131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of interferon-γ release assay to two cut-off points of tuberculin skin test to detect latent Mycobacterium tuberculosis infection in primary health care workers.
    de Souza FM; do Prado TN; Pinheiro Jdos S; Peres RL; Lacerda TC; Loureiro RB; Carvalho JA; Fregona G; Dias ES; Cosme LB; Rodrigues RR; Riley LW; Maciel EL
    PLoS One; 2014; 9(8):e102773. PubMed ID: 25137040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response.
    Esmail H; Thienemann F; Oni T; Goliath R; Wilkinson KA; Wilkinson RJ
    BMC Infect Dis; 2016 Oct; 16(1):545. PubMed ID: 27717329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new interferon gamma release assay, in comparison to tuberculin skin tests and quantiferon tuberculosis goldplus for the detection of latent tuberculosis infection in children from a high tuberculosis burden setting.
    Benachinmardi K; Sampath S; Rao M
    Int J Mycobacteriol; 2021; 10(2):142-148. PubMed ID: 34558465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals.
    Luetkemeyer AF; Charlebois ED; Flores LL; Bangsberg DR; Deeks SG; Martin JN; Havlir DV
    Am J Respir Crit Care Med; 2007 Apr; 175(7):737-42. PubMed ID: 17218620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of discordant tuberculin skin test and QuantiFERON®-TB Gold In-Tube results in various high-risk groups.
    Weinfurter P; Blumberg HM; Goldbaum G; Royce R; Pang J; Tapia J; Bethel J; Mazurek GH; Toney S; Albalak R;
    Int J Tuberc Lung Dis; 2011 Aug; 15(8):1056-61. PubMed ID: 21740668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.